ReviewClinical & developmental immunology2012
Blocking type I interferon production: a new therapeutic option to reduce the HIV-1-induced immune activation.
Moritz Ries et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this papercites it